Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce A Goldstein

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2002
In vitro human metabolism and interactions of repellent N,N-diethyl-m-toluamideKhawja A Usmani, Randy L Rose, Joyce A Goldstein, et al.
European Journal of Clinical Pharmacology|April 17, 2003
Differences in flurbiprofen pharmacokinetics between CYP2C9*1/*1, *1/*2, and *1/*3 genotypesCraig R Lee, John A Pieper, Reginald F Frye, et al.
Journal of Clinical Pharmacology|January 11, 2003
Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humansCraig R Lee, John A Pieper, Reginald F Frye, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 20, 2004
CYP2C9 genetic polymorphisms and warfarinAndrea R Redman, Leslie J Dickmann, Robert S Kidd, et al.
Pharmacogenetics|December 5, 2002
Identification and functional characterization of new potentially defective alleles of human CYP2C19Joyce Blaisdell, Harvey Mohrenweiser, Jonathan Jackson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2010
The nuclear receptors constitutive active/androstane receptor and pregnane x receptor activate the Cyp2c55 gene in mouse liverYoshihiro Konno, Hiroki Kamino, Rick Moore, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 16, 2004
CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific productsTracy C DeLozier, Cheng-Chung Tsao, Sherry J Coulter, et al.
Pharmacogenetics and Genomics|May 3, 2005
Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertensionLorraine M King, James V Gainer, Gloria L David, et al.
Pharmacogenetics and Genomics|June 20, 2014
The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotypingTaimour Y Langaee, Hao-Jie Zhu, Xinwen Wang, et al.
Pharmacogenetics|August 2, 2003
Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groupsSu-Jun Lee, Khawja A Usmani, Brian Chanas, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2002
In vitro human metabolism and interactions of repellent N,N-diethyl-m-toluamideKhawja A Usmani, Randy L Rose, Joyce A Goldstein, et al.
European Journal of Clinical Pharmacology|April 17, 2003
Differences in flurbiprofen pharmacokinetics between CYP2C9*1/*1, *1/*2, and *1/*3 genotypesCraig R Lee, John A Pieper, Reginald F Frye, et al.
Journal of Clinical Pharmacology|January 11, 2003
Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humansCraig R Lee, John A Pieper, Reginald F Frye, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 20, 2004
CYP2C9 genetic polymorphisms and warfarinAndrea R Redman, Leslie J Dickmann, Robert S Kidd, et al.
Pharmacogenetics|December 5, 2002
Identification and functional characterization of new potentially defective alleles of human CYP2C19Joyce Blaisdell, Harvey Mohrenweiser, Jonathan Jackson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2010
The nuclear receptors constitutive active/androstane receptor and pregnane x receptor activate the Cyp2c55 gene in mouse liverYoshihiro Konno, Hiroki Kamino, Rick Moore, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 16, 2004
CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific productsTracy C DeLozier, Cheng-Chung Tsao, Sherry J Coulter, et al.
Pharmacogenetics and Genomics|May 3, 2005
Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertensionLorraine M King, James V Gainer, Gloria L David, et al.
Pharmacogenetics and Genomics|June 20, 2014
The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotypingTaimour Y Langaee, Hao-Jie Zhu, Xinwen Wang, et al.
Pharmacogenetics|August 2, 2003
Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groupsSu-Jun Lee, Khawja A Usmani, Brian Chanas, et al.
Pageof 6